Huynh Cao

728 total citations
37 papers, 523 citations indexed

About

Huynh Cao is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Huynh Cao has authored 37 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Hematology and 11 papers in Immunology. Recurrent topics in Huynh Cao's work include Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (5 papers). Huynh Cao is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (5 papers). Huynh Cao collaborates with scholars based in United States, China and Taiwan. Huynh Cao's co-authors include Li‐Xi Yang, Yi Xu, Mark E. Reeves, David J. Baylink, Chien-Shing Chen, Eric H. Y. Lau, Curtis Lacy, Saied Mirshahidi, Xiaolei Tang and Samiksha Wasnik and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and International Journal of Molecular Sciences.

In The Last Decade

Huynh Cao

33 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huynh Cao United States 13 211 126 125 97 76 37 523
Katsuyoshi Kawana Japan 8 139 0.7× 125 1.0× 77 0.6× 61 0.6× 48 0.6× 11 519
Marco Benati Italy 15 286 1.4× 98 0.8× 46 0.4× 49 0.5× 63 0.8× 36 697
Hitoshi Teraoka Japan 9 141 0.7× 125 1.0× 64 0.5× 129 1.3× 25 0.3× 40 518
Federica Savi Italy 14 284 1.3× 75 0.6× 47 0.4× 115 1.2× 185 2.4× 20 746
Cen Chang China 14 245 1.2× 72 0.6× 47 0.4× 111 1.1× 68 0.9× 37 552
Kishor Devalaraja‐Narashimha United States 10 293 1.4× 137 1.1× 91 0.7× 73 0.8× 16 0.2× 15 625
Laura Kahmann Germany 7 222 1.1× 179 1.4× 90 0.7× 55 0.6× 29 0.4× 8 680
Ali N. Chamseddine France 12 287 1.4× 246 2.0× 90 0.7× 210 2.2× 36 0.5× 27 742
Hirotaka Takizawa Japan 12 166 0.8× 95 0.8× 31 0.2× 57 0.6× 22 0.3× 36 475
Hongjie Guo China 13 311 1.5× 200 1.6× 42 0.3× 205 2.1× 13 0.2× 46 731

Countries citing papers authored by Huynh Cao

Since Specialization
Citations

This map shows the geographic impact of Huynh Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huynh Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huynh Cao more than expected).

Fields of papers citing papers by Huynh Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huynh Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huynh Cao. The network helps show where Huynh Cao may publish in the future.

Co-authorship network of co-authors of Huynh Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Huynh Cao. A scholar is included among the top collaborators of Huynh Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huynh Cao. Huynh Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, B. Kevin, Joshua Kim, David J. Baylink, et al.. (2025). Nutrient-gene therapy as a strategy to enhance CAR T cell function and overcome barriers in the tumor microenvironment. Journal of Translational Medicine. 23(1). 633–633. 1 indexed citations
2.
Ahmed, Zohaib, et al.. (2024). The impact of COVID-19 mRNA vaccines on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors.. Journal of Clinical Oncology. 42(16_suppl). 2648–2648. 1 indexed citations
3.
Cao, Huynh, David J. Baylink, Vinh Nguyen, et al.. (2024). Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia. Biomedicines. 12(10). 2250–2250. 1 indexed citations
4.
Park, Daniel, Jae Min Lee, Andrea Shields, et al.. (2023). Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review. International Journal of Molecular Sciences. 24(12). 10207–10207.
5.
Xu, Yi, et al.. (2023). The potential role of the thymus in immunotherapies for acute myeloid leukemia. Frontiers in Immunology. 14. 1102517–1102517. 13 indexed citations
8.
Li, Xin, Xiaoqi Wang, Ruihao Huang, et al.. (2022). The Machine-Learning-Mediated Interface of Microbiome and Genetic Risk Stratification in Neuroblastoma Reveals Molecular Pathways Related to Patient Survival. Cancers. 14(12). 2874–2874. 11 indexed citations
9.
Xu, Yi, David J. Baylink, Mark E. Reeves, et al.. (2022). Vitamin D activates FBP1 to block the Warburg effect and modulate blast metabolism in acute myeloid leukemia. Biomarker Research. 10(1). 16–16. 8 indexed citations
10.
Reeves, Mark E., et al.. (2022). Inhibition of TKI-activated MIF/CXCR2 Pathway as a Novel Therapeutic Strategy in Acute Myeloid Leukemia. The Journal of Immunology. 208(Supplement_1). 117.20–117.20. 1 indexed citations
11.
Xu, Yi, Janet Tang, Vinh Nguyen, et al.. (2022). FBP1-Altered Carbohydrate Metabolism Reduces Leukemic Viability through Activating P53 and Modulating the Mitochondrial Quality Control System In Vitro. International Journal of Molecular Sciences. 23(19). 11387–11387. 9 indexed citations
12.
Hou, Jean, et al.. (2022). Late renal toxicity in patient with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib: A case report and literature review. Journal of Oncology Pharmacy Practice. 28(8). 1930–1935. 2 indexed citations
13.
Cao, Huynh, Do Hyun Kim, Ashley Howard, et al.. (2021). Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients’ bone marrow. Neoplasia. 23(12). 1252–1260. 8 indexed citations
14.
Xu, Yi, David J. Baylink, Chien-Shing Chen, et al.. (2020). The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. Journal of Translational Medicine. 18(1). 322–322. 126 indexed citations
15.
Xu, Yi, Kimberly J. Payne, David Chi, et al.. (2020). A novel vitamin D gene therapy for acute myeloid leukemia. Translational Oncology. 13(12). 100869–100869. 13 indexed citations
16.
Cao, Huynh, Yi Xu, Rosalia de Necochea-Campion, et al.. (2017). Application of vitamin D and vitamin D analogs in acute myelogenous leukemia. Experimental Hematology. 50. 1–12. 28 indexed citations
17.
Raza, Anwar, Huynh Cao, Camilla J. Cobb, et al.. (2015). Nuclear protein in testis midline carcinoma with unusual elevation of α-fetoprotein and synaptophysin positivity: a case report and review of the literature. Expert Review of Anticancer Therapy. 15(10). 1199–1213. 12 indexed citations
18.
Cao, Huynh, et al.. (2014). Cardiotoxicity of molecular-targeted drug therapy.. PubMed. 34(7). 3243–9. 11 indexed citations
19.
Cao, Huynh, et al.. (2013). Current status in chemotherapy for advanced pancreatic adenocarcinoma.. PubMed. 33(5). 1785–91. 37 indexed citations
20.
Cao, Huynh, Chi Lai, Christian Head, & Joel A. Sercarz. (2008). Cystic parathyroid presenting as an apparent thyroid goiter. European Archives of Oto-Rhino-Laryngology. 265(10). 1285–1288. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026